“…In order to establish the experimental protocol for loading biologics on CaP nanoparticles, bovine serum albumin (BSA, ≥96%, Sigma-Aldrich, Stockholm, Sweden, MW: 66430.3 g/mol) and bradykinin acetate salt (≥98%, Sigma-Aldrich, Stockholm, Sweden, MW: 1060.2 g/mol) were selected as model protein and peptide, respectively. BSA was selected as model protein because of its stability and its wide application in evaluating sustained drug release systems [55,56], whereas bradykinin is rather small and can act as model for the loading of larger ones. Further on, as a case study LL-37 antimicrobial peptide (LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES, >95%, Innovagen, Lund, Sweden, MW: 4493.3 g/mol) was loaded on CaP nanoparticles and the antibacterial efficiency of the LL-37-CaP nanoconjugates was evaluated.…”